Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations

NCT07369596 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Carcinoma NSCLC

Interventions

OTHER: Progression free survival
OTHER: Overall survival

Sponsor

University of Malaya